Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Cellcolabs Clinical AB
AB
Active
Org 5595011254
Scheeles Väg 5, 171 65
Solna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 1 year old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cellcolabs Clinical AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SJ
Sandra Jenny Carina Lindvall
Chief Auditor
Chief Auditor
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
EK
Emma Katarina Hendéus Levén
Board of Directors
Board of Directors
2024
PE
Petter Emanuel Hallman
Chairman
Chairman
2024
MJ
Mattias Jens Edvard Bernow
Board of Directors
Board of Directors
2024
Former (2)
RA
Rolf Andreas Sjödin
Deputy Board Member
Deputy Board Member
2024 – 2024
LO
Lars Olof Hellman
Board of Directors
Board of Directors
2024 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Cellcolabs Clinical AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
